Sarko Genus Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-01-2025
- Paid Up Capital ₹ 0.50 M
as on 09-01-2025
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -44.93%
(FY 2019)
- Profit 2666.46%
(FY 2019)
- Ebitda -49.89%
(FY 2019)
- Net Worth 4.75%
(FY 2019)
- Total Assets -18.30%
(FY 2019)
About Sarko Genus Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Abhineet Shankar, Shaivalini Sinha, Abhijeet Shankar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33100DL2015PTC278506
- Company No.
278506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2015
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarko Genus Lifesciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhineet Shankar  | Director | 30-Mar-2015 | Current |
| Abhijeet Shankar | Director | 30-Mar-2015 | Current |
| Shaivalini Sinha | Director | 30-Mar-2015 | Current |
| Sudeep Verma | Director | 30-Mar-2015 | Current |
| Tanvi Verma | Director | 30-Mar-2015 | Current |
Financial Performance of Sarko Genus Lifesciences.
Sarko Genus Lifesciences Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 44.93% decrease. The company also saw a substantial improvement in profitability, with a 2666.46% increase in profit. The company's net worth moved up by a moderate rise of 4.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarko Genus Lifesciences?
In 2019, Sarko Genus Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shankar Ganpati Engineering Consultancy Private LimitedActive 13 years 8 monthsAbhineet Shankar, Shaivalini Sinha and 1 more are mutual person
- Sarwangin Educational Development FoundationActive 10 years 3 months
Abhineet Shankar, Abhijeet Shankar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarko Genus Lifesciences?
Unlock and access historical data on people associated with Sarko Genus Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarko Genus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarko Genus Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.